Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

1H-1,2,3-Triazole-4-carboxamide, 1-((2,6-difluorophenyl)methyl)-

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

17 API Suppliers, 9 USDMF, 3 EU WC, 8 NDC API, 8 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

52 FDF Dossiers, 27 FDA Orange Book, 20 Europe, 5 Canada

DRUG PRODUCT COMPOSITIONS

SUSPENSION;ORAL - 40MG/ML, TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 200MG, TABLET;ORAL - 400MG

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 7 SPI Pharma, 11 DKSH, 4 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 15 BASF, 10 Corel Pharma Chem, 4 DFE Pharma, 1 Esteem Industries, 2 Finar, 6 Gangwal Chemicals, 4 Ideal Cures, 2 Ingredion Pharma Solutions, 19 Kerry, 2 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 24 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Silverline Chemicals, 3 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 45 Fillers, Diluents & Binders, 31 Thickeners and Stabilizers, 21 Direct Compression, 20 Controlled & Modified Release, 19 Granulation, 17 Film Formers & Plasticizers, 16 Topical, 14 Lubricants & Glidants, 13 Taste Masking, 12 Rheology Modifiers, 11 Solubilizers, 11 Co-Processed Excipients, 9 Chewable & Orodispersible Aids, 9 Disintegrants & Superdisintegrants, 6 Emulsifying Agents, 5 Parenteral, 5 Empty Capsules, 4 Coloring Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 2 Surfactant & Foaming Agents, 1 Soft Gelatin

DIGITAL CONTENT

22 News #PharmaBuzz

22 News #PharmaBuzz

GLOBAL SALES INFORMATION

9 US Medicaid Prescriptions, 12 Regulatory FDF Prices, 14 Annual Reports

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

4 Health Canada Patents

4 Health Canada Patents

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
12/12/2025	Lupin Manufacturing Solutions	India	LUPIN MANUFACTURING SOLUTIONS LTD	26316	RUFINAMIDE USP	2012-10-09	Active	II	Complete	2013-04-23	2012-11-13
29/11/2025	Alivus Life Sciences	India	ALIVUS LIFE SCIENCES LTD	26209	RUFINAMIDE	2012-10-23	Active	II	Complete	2013-04-24	2012-11-06

1H-1,2,3-Triazole-4-carboxamide, 1-((2,6-difluorophenyl)methyl)-

1H-1,2,3-Triazole-4-carboxamide, 1-((2,6-difluorophenyl)methyl)-

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

17 API Suppliers

9 USDMF

3 EU WC

8 NDC API

8 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

8 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

52 FDF Dossiers

27 FDA Orange Book

20 Europe

5 Canada

DRUG PRODUCT COMPOSITIONS

SUSPENSION;ORAL - 40MG/ML

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 200MG

TABLET;ORAL - 400MG

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc

7 SPI Pharma

11 DKSH

4 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

1 Kirsch Pharma

1 ACG Worldwide

3 Actylis

1 Aeon Procare

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

15 BASF

10 Corel Pharma Chem

4 DFE Pharma

1 Esteem Industries

2 Finar

6 Gangwal Chemicals

4 Ideal Cures

2 Ingredion Pharma Solutions

19 Kerry

2 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

1 Novo Excipients

1 Pharmatrans-Sanaq

4 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

24 Roquette

7 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

2 Silverline Chemicals

3 The Dow Chemical Company

1 Valens Pharmachem

2 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives

45 Fillers, Diluents & Binders

31 Thickeners and Stabilizers

21 Direct Compression

20 Controlled & Modified Release

19 Granulation

17 Film Formers & Plasticizers

16 Topical

TABLET;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons